Background: Elevations in blood lactate levels have been associated with poor postoperative outcome. The aim of the present study was to determine if preoperative supplementation with branched-chain amino acids (BCAA) decreases postoperative blood lactate levels in patients undergoing pancreatoduodenectomy. Methods: The cases of 223 consecutive patients who underwent pancreatoduodenectomy were retrospectively reviewed. Postoperative blood lactate levels in patients who were treated with BCAA supplementation before pancreatoduodenectomy (December 2011-December 2014) were compared with levels in patients who were not pretreated (January 2008-November 2011. Results: Postoperative lactate levels were significantly lower in patients who received preoperative BCAA supplementation than in patients who did not (2.6 vs 3.1 mmol/L, P = .005), although preoperative blood lactate levels were statistically equivalent between the groups. In the univariate analysis, preoperative BCAA supplementation, preoperative lactate levels, operation time, and postoperative glucose levels were associated with postoperative lactate levels. A multiple regression analysis was performed among the 4 factors, and the preoperative use of BCAA supplementation was independently correlated with postoperative lactate levels (P = .046). Conclusions: Preoperative BCAA supplementation decreased postoperative blood lactate levels. These results suggest that preoperative BCAA supplementation may help patients recover after surgery. (JPEN J Parenter Enteral Nutr. 2018;42:960-964) 
Introduction
Elevated blood lactate levels are often observed during periods of physiologic and pathophysiologic stress, including surgery. Elevated lactate levels were reported to be associated with an increased risk of intraoperative complications and poor postoperative outcome. 1, 2 Perioperative management strategies with the goal of maintaining normal blood lactate levels have been shown to reduce morbidity rates after major elective abdominal surgery. 3 Previous reports have shown that branched-chain amino acid (BCAA) supplementation prior to exercise increased BCAA oxidation and suppressed lactate production. 4 Here, we conducted the first clinical study to examine the effect of preoperative BCAA supplementation on postoperative lactate levels in patients undergoing pancreatoduodenectomy.
Materials and Methods

Study Subjects and Perioperative Management
This is a retrospective cohort study of 268 consecutive patients who underwent pancreatoduodenectomy between January 2008 and December 2014 at Kobe University Hospital. Perioperative data from patients receiving preoperative BCAA supplementation (December 2011-December 2014) were compared with those from patients who did not receive preoperative BCAA supplementation (January 2008-November 2011). In those patients who received BCAA supplementation, a 500-mL oral supplement (AminoValue; Otsuka Pharmaceutical, Tokyo, Japan) was administered preoperatively until 2 hours prior to anesthesia. The nutrient profile of the BCAA beverage is shown in Table 1 , and details of the perioperative management strategy are shown in Table 2 . Patients in each group received the same perioperative management throughout the study period, with the exception of preoperative BCAA supplementation. The Institutional Review Board of the Kobe University Hospital approved the research protocol for this retrospective cohort study.
Data Collection
Clinical data were retrospectively collected from the medical record and anesthesia chart for each patient. Preoperative blood samples were obtained from a radial artery blood pressure catheter just after intubation, as part of routine perioperative monitoring, and arterial blood gas analysis was performed (ABL700; Radiometer Medical, Tokyo, Japan). Postoperative blood samples were obtained from the same catheter while the patient was recovering in the intensive care unit. In this study, intraoperative vasopressor Patients were admitted 1 d prior to surgery, and normal hospital lunch and dinner were served; intake of solid foods was not allowed thereafter. Clear fluids were permitted until 2 h before anesthesia. Oral bowel preparation Mechanical bowel preparation was done with 50 g of magnesium citrate diluted with 180 mL of water on the day before surgery. Operative management Preanesthetic and postanesthetic management A central venous catheter was inserted into the right internal jugular vein to help guide fluid management. No intravenous fluids were given preoperatively. A blood pressure catheter was inserted into the left radial artery just after intubation for perioperative monitoring.
Antimicrobial prophylaxis
Antimicrobial prophylaxis was used in a single-dose manner initiated 30-60 min before skin incision and was repeated intraoperatively. Epidural analgesia Before induction of anesthesia, patients received midthoracic epidural analgesia for pain relief unless contraindicated. Anesthesia
General anesthesia was induced with propofol and fentanyl and maintained under general inhalation anesthesia. Fluid management Balanced crystalloids were used to maintain fluid volume during surgery, and neither lactated Ringer solution nor 0.9% saline was used. Colloid solutions and blood transfusions, as well as vasopressors, were used according to the preference of the anesthetist. Avoiding hypothermia
Patients were actively warmed with a forced-air garnet system. Glycemic control Hyperglycemia >200 mg/dL was treated with intravenous insulin.
Postoperative transfer
Patients were transferred to the intensive care unit for postsurgical management. 
Statistics
The primary outcome was a decrease in postoperative blood lactate level, and the secondary outcome was a decrease in postoperative morbidity. Between-group differences were assessed with the χ 2 test for categorical variables and Student's t test for continuous variables. To elucidate the clinical factors that affected postoperative blood lactate levels, univariate analyses were performed between postoperative lactate levels and perioperative variables: linear regression analyses for continuous variables and Student's t test for categorical variables. Statistically significant variables in the univariate analyses were further evaluated in a multiple regression analysis. All reported P values were 2-sided and considered significant if <.05. All analyses were performed with JMP 12.2 for Macintosh (SAS Institute, Inc, Cary, NC).
Results
Patient Characteristics
A total of 268 patients were enrolled in the study, and 40 were excluded for the following reasons: 20 had prolonged preoperative fasting; 7 were not extubated immediately after surgery; 1 had total intravenous anesthesia; and 12 had no record of postoperative lactate level. In summary, the cases of 121 patients with preoperative BCAA supplementation and 107 without were analyzed. The preoperative characteristics of the patients in each group were statistically equivalent, including blood lactate levels (Table 3) .
Comparisons Based on Preoperative Use of BCAA Supplementation
Postoperative blood lactate levels were significantly lower in those patients who received preoperative BCAA supplementation than in those who did not (2.6 vs 3.1 mmol/L, P = .006; Figure 1 ). However, there were no differences in the rate of grade III-IV morbidity (24% vs 28%, P = .503; Table 3 ).
Univariate and multivariate analyses were used to assess clinical factors that affected postoperative blood lactate levels. Univariate analysis revealed that preoperative BCAA supplementation (P = .006), preoperative lactate levels (P < .001), operation time (P = .003), and postoperative glucose levels (P < .001) significantly affected postoperative lactate levels (Table 3 ). In the multivariate analysis, preoperative BCAA supplementation was independently associated with decreased postoperative lactate levels (P = .045; Table 4 ).
Discussion
Current evidence regarding the most appropriate strategies for managing surgical stress and enhancing recovery after surgery is limited and incomplete. This novel clinical study demonstrates that preoperative BCAA supplementation decreases serum lactate levels after pancreatoduodenectomy. Although multiple factors influenced postoperative lactate levels in the univariate analysis, it is worth noting that use of preoperative BCAA supplementation remained an independent determinant of low postoperative lactate in the multivariate analysis. In this small pilot study, preoperative BCAA supplementation did not show a morbidity benefit, and we are unable to conclude that preoperative BCAA supplementation alone had a significant clinical impact. However, our results suggest that preoperative BCAA supplementation could be 1 part of a multidisciplinary approach to enhancing recovery from surgery. Recent evidence suggests that elevated lactate levels are not merely a consequence of anaerobic glycolysis but rather physiologic and pathophysiological stress in the context of normal tissue oxygenation. 5 BCAA supplementation has been shown to suppress oxidative stress and inflammation. 6 It seems possible that, in the perioperative setting, BCAA supplementation reduces lactate production through antiinflammatory processes.
The current study has several limitations. This was a small retrospective study. A larger, prospective study is required to confirm our results.
In conclusion, the current study found that preoperative BCAA supplementation decreases postoperative blood lactate levels. Our results suggest that preoperative BCAA supplementation may enhance recovery after surgery.
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